We have successfully used this approach to show that kRASG12D collaborates with p53 loss to induce early onset embryonal rhabdomyosarcoma [22] and work from Feng et al., elegantly showed that mosaic transgenesis can be used to modify Myc-induced T-ALL through coinjection of activated Akt [10]. Here, MYC is linked to acute lymphoblastic leukemia.